The article discusses a groundbreaking study aimed at children with peanut allergies who can tolerate small amounts. At the Food Allergy Institute, customized treatments using AI technology are being explored. A clinical trial involved administering increasing amounts of peanut butter to children aged 4-14, where 68% achieved tolerance compared to just 8% in the avoidance group. This innovative, accessible approach provides hope for many kids who previously had no alternatives other than strict avoidance or more expensive treatments, though some side effects were noted during the trial.
This easy and accessible treatment strategy could potentially fulfill an unmet need for about half of children with high threshold peanut allergies.
In a new National Institutes of Health trial, Mt. Sinai researchers used a similar approach, administering store-bought peanut butter on a small group of 4-to-14 year olds.
Collection
[
|
...
]